Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000239290 | SCV000297149 | benign | not specified | 2015-08-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313966 | SCV000848836 | benign | Inborn genetic diseases | 2017-01-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000862765 | SCV001003316 | benign | Spastic paraplegia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610545 | SCV001833167 | benign | not provided | 2019-04-04 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001610545 | SCV001927797 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001610545 | SCV001974203 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003909875 | SCV004720334 | likely benign | KDM5C-related disorder | 2021-06-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |